<DOC>
	<DOC>NCT02943239</DOC>
	<brief_summary>Assess the safety and tolerability of REGN2477 alone and combined with REGN1033 in health postmenopausal women.</brief_summary>
	<brief_title>Study of Safety, Tolerability, and Pharmacokinetics of REGN2477 Alone and in Combination With REGN1033 in Healthy Postmenopausal Women</brief_title>
	<detailed_description>Assess the safety and tolerability of REGN2477 alone and combined with REGN1033 in health postmenopausal women. Effect of REGN2477 alone, REGN1033 alone and REGN2477+REGN1033 in combination on muscle and body composition. Measure amount of REGN2477 and REGN1033 in blood. Assess presence or absence of antibodies for REGN2477 or REGN1033.</detailed_description>
	<criteria>Postmenopausal women age 45 to 70 years BMI between 18 to 32 kg/m2, inclusive Willing and able to maintain current diet, supplements and physical activity level throughout the study Provides signed informed consent Significant illness or history of significant illness Contraindication to MRI History of human immunodeficiency virus (HIV); hepatitis B or hepatitis C virus (HCV) History of immobilization, major surgical procedure, fracture, or major trauma within 9 months prior to screening History of significant gynecological disorders or malignancies; history of breast malignancies (uterine fibroids or dysfunctional uterine bleeding is acceptable) Inconsistent vigorous physical activity (on fewer than 5 days per week), such as intermittent weight lifting History of hypersensitivity reactions to tetracycline antibiotics (includes doxycycline), vaccines, or biologics Use of agents that alter muscle mass that have not been at a stable dose for 3 months prior to screening (includes protein supplements), or use of any weight altering or anabolic steroid drugs (includes drugs for obesity, diuretics, testosterone) Patients treated with a biologic therapy or biologic immunotherapy in the previous 12 weeks prior to screening and during the study</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>